iBio, Inc.IBIONYSE

Revenue (LTM)

$400000

+77.8% YoY

Net Income (LTM)

$-18M

+26.2% YoY

Free Cash Flow

$-15M

Revenue CAGR (5Y)

-35.9%

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Revenue	2	2↓20.5%	0	0	0↑77.8%
Gross Profit	1	-2↓309.8%	0	0	0↑77.8%
Operating Income	-31	-30↑4.5%	-29↑1.2%	-17↑43.3%	-19↓11.8%
Net Income	-23	-50↓117.1%	-65↓29.0%	-25↑61.7%	-18↑26.2%
EBITDA	-29	-26↑9.9%	-28↓8.3%	-14↑49.7%	-17↓21.5%
EPS Diluted	-59.98	-2889.06↓4716.7%	-106.18↑96.3%	-6.50↑93.9%	-1.75↑73.1%

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Cash & Equivalents	77	23↓70.7%	7↓67.7%	14↑94.0%	9↓39.6%
Total Current Assets	105	45↓56.9%	26↓41.7%	16↓40.3%	10↓38.0%
Total Assets	147	99↓32.4%	41↓58.5%	29↓30.3%	23↓19.3%
Total Current Liabilities	7	30↑358.0%	22↓29.1%	4↓82.2%	6↑59.0%
Total Liabilities	38	36↓6.5%	26↓28.1%	7↓71.3%	8↑12.1%
Total Equity	109	63↓41.5%	15↓75.8%	21↑38.6%	15↓30.2%
Total Debt	33	26↓21.3%	17↓33.7%	4↓73.9%	4↓21.3%
Net Debt	-45	3↑106.9%	10↑215.5%	-10↓200.0%	-5↑48.0%

Metric	Jun 21	Jun 22	Jun 23	Jun 24	Jun 25
Operating Cash Flow	-30	-38↓25.7%	-30↑19.5%	-19↑39.0%	-15↑17.5%
Capital Expenditure	-5	-7↓42.0%	-6↑21.7%	-0↑96.3%	-0↑92.4%
Free Cash Flow	-35	-45↓28.1%	-36↑19.8%	-19↑48.1%	-15↑18.4%
Stock-Based Comp	2	0	4	2↓53.6%	2↓24.9%
Net Change in Cash	22	-55↓345.5%	-21↑61.5%	7↑132.5%	-6↓182.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance